Final Alert: New Weed Stock Posting at 11:05 am ET Tomorrow

[Zacks | Our Research. Your Success.] Last Chance to Beat Wall Street to This Ticker Zacks Member, Did you miss my earlier email? I want to give you one more chance to ride the historic growth trajectory of legal marijuana from $24.6 billion in 2020 as it explodes to an expected $86 billion by 2028.¹ This estimate might be conservative. In the election, all 6 referendums were approved in 5 states. Now 37 states plus D.C. allow medical marijuana and 17 plus D.C. have legalized recreational weed. Legalization has already swept throughout Canada, and Mexico plans to follow next month. This would leave the U.S. as the only North American country not collecting national tax revenues from a rampantly growing industry. Change is inevitable and also imminent -- and this will be the real jackpot for investors. New companies will emerge. Current stocks could skyrocket. Zacks' Marijuana Innovators portfolio recently closed trades of +147.0%, in Innovative Industrial Properties, +39.7% in Aurora Cannabis, and +94.5% in GrowGeneration in as little as 3 months. Right now we're still riding 2 giant gains of +240.8% and +152.2%.² We bought those 2 companies near their lows and, in my view, they still have a long way to run which can be very good news for you. Even better, I'm lining up strong U.S.-listed companies that could rival or surpass those gains. I should mention that our approach avoids the dicey penny stocks, targeting the few growers, pharmaceuticals, financial firms, suppliers - both established and start-ups - that are the true innovators and offer the most reliable potential for double and triple-digit gains. Monday morning at 11:05 am ET, I'll post a big pharmaceutical stock with a much bigger upside. I've been tracking this impressive company and it has recently purchased a leading cannabis pharma player. Its price could skyrocket in the coming weeks and months. Don't miss your opportunity to get in early. It couldn't be easier to gain 30-day access to the buys, sells, and commentary of our Marijuana Innovators portfolio. Your total cost? Only $1. But please remember that we can't allow too many investors to jump on our selected stocks. The portfolio has been closed since December. Re-opened briefly, it closes to entry again just hours from now - midnight tonight, Sunday, June 6. I look forward to sharing this generational investment opportunity with you at the ideal time. Vaccinations are in full-blown rollout. Trillions in stimulus are pouring into the economy just as pent-up consumer demand is unleashing. And the new legal marijuana industry is entering its phase of explosive growth. [▶ See Stocks Now]( All the Best, [David Borun - signature] David Borun Editor of Marijuana Innovators ¹ Grand View Research ² As of 6/2/2021. The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. This free resource is being sent by [Zacks.com](. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service". [(. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through May 3, 2021. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit [( for information about the performance numbers displayed above. Zacks Emails If you would prefer to not receive future profit-producing emails from [Zacks.com]( the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please [click here]( and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606